Overview
Arati Rao is a Hematologist and an Oncologist practicing medicine in Durham, North Carolina.
Dr. Rao is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Mantle Cell Lymphoma (MCL), and Chronic Myelogenous Leukemia (CML).
She is actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
111G Va Medical Ctr 508 Fu St, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UNC Hospitals Outpatient Center At Eastowne
Nigel Key is a Hematologist and an Oncologist practicing medicine in Chapel Hill, North Carolina. Dr. Key is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Hemophilia B, Hemophilia A, Blood Clots, and Sickle Cell Disease.
UNC Hospitals Pulmonary Function Lab
Paul Monahan is a Hematologist and an Oncologist practicing medicine in Chapel Hill, North Carolina. Dr. Monahan is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hemophilia B, Blood Clots, Hemophilia A, and Hemophilic Arthropathy.
Duke University Health System Inc
David Ashley is a Hematologist and an Oncologist practicing medicine in Durham, North Carolina. Dr. Ashley is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.
Frequently Asked Questions about Dr. Arati Rao
How do I make an appointment with Dr. Arati Rao?
You can book an appointment with Dr. Arati Rao by calling their office at 919-286-6944. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Arati Rao a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arati Rao is classified as an Advanced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Arati Rao specialize in?
While Dr. Arati Rao is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Leukemia, and Mantle Cell Lymphoma (MCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Arati Rao participate in research or clinical trials?
Yes. Dr. Arati Rao has published 23 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Arati Rao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- LeukemiaDr. Rao isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Ataxia-Pancytopenia SyndromeDr. Rao isExperienced. Learn about Ataxia-Pancytopenia Syndrome.
- Childhood Acute Myeloid LeukemiaDr. Rao isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)